The FDA may not renew Pfizer's Covid-19 vaccine for young children this fall, leaving a significant gap in vaccination options.
This decision could remove the only vaccine available for children under five, impacting their protection against the virus.
Moderna's vaccine, approved only for children with pre-existing conditions, might partially fill the void, but not completely.
Experts express concern about this potential shortage, especially given already low vaccination rates among young children.
